Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 3,681 | 2,765 | 1,502 | 2,868 | 3,779 |
| Cost of Goods | 5 | 39 | 36 | 154 | 38 |
| Gross Profit | 3,676 | 2,726 | 1,466 | 2,714 | 3,741 |
| Operating Expenses | 7,467 | 22,545 | 8,007 | 7,978 | 7,619 |
| Operating Income | -3,786 | -19,780 | -6,505 | -5,110 | -3,840 |
| Other Income | -25,966 | -10,584 | 2,362 | 1,860 | 839 |
| Pre-tax Income | -29,752 | -30,364 | -4,143 | -3,250 | -3,001 |
| Net Income Continuous | -29,752 | -30,364 | -4,143 | -3,250 | -3,001 |
| Minority Interests | 29 | 100 | -4 | 23 | 33 |
| Net Income | $-29,781 | $-30,464 | $-4,139 | $-3,273 | $-3,034 |
| EPS Basic Total Ops | -0.13 | -0.13 | -0.02 | 0.00 | -0.02 |
| EPS Basic Continuous Ops | -0.13 | -0.13 | -0.02 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.13 | -0.13 | -0.02 | 0.00 | -0.02 |
| EPS Diluted Continuous Ops | -0.13 | -0.13 | -0.02 | -0.01 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.01 | -0.02 | -0.01 | -0.02 |
| EBITDA(a) | $-3,561 | $-4,857 | $-6,341 | $-4,970 | $-3,710 |